NCT07518056

Brief Summary

The purpose of this study is to examine the effects of nomophobia levels on stress, food addiction, and body image among undergraduate students aged 18-30 at Bahçeşehir University, Faculty of Health Sciences. The primary questions it aims to answer are:

  • Is there a statistically significant relationship between nomophobia levels and perceived stress, food addiction, and body image among university students?
  • Is there a correlation between objective anthropometric data (body fat percentage, skeletal muscle mass) measured via Bioelectrical Impedance Analysis (BIA), waist/hip circumference measurements, and the individual's perceived body image?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 2, 2026

Last Update Submit

April 15, 2026

Conditions

Keywords

nomophobiastressbody imagefood addiction

Outcome Measures

Primary Outcomes (1)

  • Nomophobia

    The level of nomophobia experienced by participants, measured using the Nomophobia Questionnaire (NMP-Q). This form aims to assess your feelings and thoughts when you cannot access your smartphone or are away from it, a condition known as nomophobia. There are no right or wrong answers; what matters is answering honestly based on your own experience. Indicate your level of agreement with each statement about your smartphone use (1 = strongly agree, 7 = strongly disagree).

    Baseline

Secondary Outcomes (3)

  • Perceived Stress

    Baseline

  • Body Image

    Baseline

  • Food Addiction

    Baseline

Study Arms (1)

University Students

Participants (n:150) will complete questionnaires assessing nomophobia, perceived stress, body image, and food addiction. In addition, objective anthropometric measurements, including body composition (fat mass, muscle mass) via Bioelectrical Impedance Analysis (InBody 270) and waist-to-hip ratio measurements, will be collected. No drugs or treatments are administered.

Other: Questionnaires on Nomophobia, Perceived Stress, Body Image, and Food Addiction; Body Composition and Anthropometric Measurements via Bioelectrical Impedance Analysis

Interventions

Participants will complete self-report questionnaires including the Nomophobia Questionnaire (NMP-Q), Perceived Stress Scale (PSS-10), Body Image Questionnaire (BIQ), Food Addiction Scale (YFAS 2.0), and the Stunkard Figure Rating Scale (FRS). Objective anthropometric measurements, including body composition using InBody 270 and waist-to-hip ratio, will also be obtained.

University Students

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of university students who are active smartphone users and have provided informed consent. Participants do not have pacemakers, metallic prostheses, or pregnancy, and they do not have diagnosed metabolic disorders (e.g., Cushing's syndrome, diabetes, thyroid disorders) or psychiatric conditions that could affect eating behavior. Individuals with current eating disorders, severe psychiatric diagnoses, regular use of psychiatric medications, recent corticosteroid or hormone therapy, or those who do not complete the questionnaires and measurement procedures are excluded.

You may qualify if:

  • Being an active smartphone user
  • Reading and providing consent via the Informed Consent Form
  • Absence of conditions such as pacemaker implantation, metallic prostheses in the body, or pregnancy
  • Not having a diagnosed metabolic disorder (e.g., Cushing's syndrome, diabetes, thyroid disorders) or any acute/chronic psychiatric condition that may affect eating behavior

You may not qualify if:

  • Individuals with a current diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.)
  • Individuals with a psychiatric diagnosis of severe depression, bipolar disorder, psychotic disorder, or an anxiety disorder requiring treatment
  • Individuals who regularly use psychiatric medications (e.g., SSRIs, SNRIs, antipsychotics, mood stabilizers, etc.)
  • Individuals who have used corticosteroids or similar hormone-regulating medications in the past 3 months
  • Pregnant or breastfeeding individuals
  • Participants who did not complete the questionnaires or the measurement procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bahçeşehir University, Faculty of Health Sciences

Istanbul, beşiktaş, 34353, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Body Dysmorphic DisordersFood Addiction

Interventions

Body Composition

Condition Hierarchy (Ancestors)

Somatoform DisordersMental DisordersBehavior, AddictiveCompulsive BehaviorImpulsive BehaviorBehaviorFeeding and Eating Disorders

Intervention Hierarchy (Ancestors)

Biochemical PhenomenaChemical PhenomenaMetabolismBody ConstitutionPhysiological Phenomena

Study Officials

  • Beyza Terzioğlu

    Bahçeşehir University

    PRINCIPAL INVESTIGATOR
  • Ecenur Özkul Erdoğan, PhD

    Bahçeşehir University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dietitian

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 8, 2026

Study Start

February 10, 2026

Primary Completion

April 1, 2026

Study Completion

May 1, 2026

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

No individual participant data (IPD) will be shared with other researchers. Individual-level data will remain confidential in accordance with data protection regulations (e.g., KVKK); however, aggregated data, summary statistics, and group-level results may be reported in publications and presentations.

Locations